4 Firms Guide French Biotech Firm Abivax's $236M US IPO
French biotechnology firm Abivax SA raised $236 million Friday in a U.S. initial public offering that priced at the bottom of its revised range and fell in debut trading, guided by...To view the full article, register now.
Already a subscriber? Click here to view full article